The experimental validation, encompassing bisulfite sequencing and ROC curve analysis, provides strong evidence linking reduced promoter methylation to the overexpression of OAS family genes, thereby reinforcing their role as potential epigenetic biomarkers for breast cancer detection. The gene discussed is SMOC1; the disease is breast cancer.